SANDS ARTHUR T 4
4 · Nurix Therapeutics, Inc. · Filed Feb 15, 2024
Insider Transaction Report
Form 4
SANDS ARTHUR T
DirectorPresident, CEO
Transactions
- Award
Employee Stock Option (right to buy)
2024-02-13+800,000→ 800,000 totalExercise: $8.72Exp: 2034-02-12→ Common Stock (800,000 underlying)
Footnotes (1)
- [F1]The stock option vests as to 1/36 of the total shares monthly beginning March 13, 2024, until the option is fully vested on February 13, 2027, subject to the Reporting Person's provision of service to the Issuer on each vesting date.